Exosomes as divine messengers: are they the Hermes of modern molecular oncology? C Braicu, C Tomuleasa, P Monroig, A Cucuianu, I Berindan-Neagoe, ... Cell Death & Differentiation 22 (1), 34-45, 2015 | 310 | 2015 |
Human bile contains microRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis L Li, D Masica, M Ishida, C Tomuleasa, S Umegaki, AN Kalloo, ... Hepatology 60 (3), 896-907, 2014 | 235 | 2014 |
The new era of nanotechnology, an alternative to change cancer treatment A Jurj, C Braicu, LA Pop, C Tomuleasa, CD Gherman, I Berindan-Neagoe Drug design, development and therapy, 2871-2890, 2017 | 175 | 2017 |
Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. C Tomuleasa, O Soritau, D Rus-Ciuca, T Pop, D Todea, O Mosteanu, ... Journal of Gastrointestinal & Liver Diseases 19 (1), 2010 | 138 | 2010 |
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells C Tomuleasa, O Soritau, A Orza, M Dudea, B Petrushev, O Mosteanu, ... J Gastrointestin Liver Dis 21 (2), 187-196, 2012 | 135 | 2012 |
A comprehensive picture of extracellular vesicles and their contents. Molecular transfer to cancer cells A Jurj, O Zanoaga, C Braicu, V Lazar, C Tomuleasa, A Irimie, ... Cancers 12 (2), 298, 2020 | 109 | 2020 |
Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ... J Gastrointestin Liver Dis 24 (4), 435-443, 2015 | 100 | 2015 |
MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer S Yamanaka, AV Olaru, F An, D Luvsanjav, Z Jin, R Agarwal, ... Digestive and Liver Disease 44 (7), 589-596, 2012 | 89 | 2012 |
Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched … S Gaballa, I Ge, R El Fakih, JE Brammer, P Kongtim, C Tomuleasa, ... Cancer 122 (21), 3316-3326, 2016 | 81 | 2016 |
MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog L Li, L Zhou, Y Li, S Lin, C Tomuleasa J buon 19 (1), 228-236, 2014 | 78 | 2014 |
How to diagnose and treat a cancer of unknown primary site. C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ... Journal of Gastrointestinal & Liver Diseases 26 (1), 2017 | 77 | 2017 |
Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma H Peng, M Ishida, L Li, A Saito, A Kamiya, JP Hamilton, R Fu, AV Olaru, ... Oncotarget 6 (8), 5666, 2015 | 77 | 2015 |
Nanopharmacology in translational hematology and oncology C Tomuleasa, C Braicu, A Irimie, L Craciun, I Berindan-Neagoe International Journal of Nanomedicine, 3465-3479, 2014 | 68 | 2014 |
Nanomedicine approaches in acute lymphoblastic leukemia AS Tatar, T Nagy-Simon, C Tomuleasa, S Boca, S Astilean Journal of Controlled Release 238, 123-138, 2016 | 65 | 2016 |
SERS liquid biopsy: An emerging tool for medical diagnosis V Moisoiu, SD Iancu, A Stefancu, T Moisoiu, B Pardini, MP Dragomir, ... Colloids and Surfaces B: Biointerfaces 208, 112064, 2021 | 63 | 2021 |
Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells MD Aldea, B Petrushev, O Soritau, CI Tomuleasa, I Berindan-Neagoe, ... J buon 19 (2), 502-511, 2014 | 63 | 2014 |
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles A Orza, O Soriţău, C Tomuleasa, L Olenic, A Florea, O Pana, I Bratu, ... International journal of nanomedicine, 689-702, 2013 | 62 | 2013 |
A narrative review of central nervous system involvement in acute leukemias D Deak, N Gorcea-Andronic, V Sas, P Teodorescu, C Constantinescu, ... Annals of translational medicine 9 (1), 2021 | 61 | 2021 |
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations MY Shah, M Ferracin, V Pileczki, B Chen, R Redis, L Fabris, X Zhang, ... Genome research 28 (4), 432-447, 2018 | 60 | 2018 |
Glioblastoma stem cells: a new target for metformin and arsenic trioxide M Carmignani, AR Volpe, M Aldea, O Soritau, A Irimie, IS Florian, ... J Biol Regul Homeost Agents 28 (1), 1-15, 2014 | 58 | 2014 |